Treatment pattern and outcomes of trifluridine/tipiracil therapy for metastatic colorectal cancer in the real-world data from the JFMC50 study

T. Kawakami, K. Yamazaki, E. Oki, M. Shimokawa, N. Takahashi, M. Yokota, S. Tokunaga, T. Esaki, M. Gamoh, A. Maeda, Y. Tsuji, A. Sakai, K. Hatanaka, Y. Shimada, M. Shiozawa, Y. Komatsu, H. Okuda, M. Ohue, Y. Maehara

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)viii155
JournalAnnals of oncology : official journal of the European Society for Medical Oncology
Volume29
DOIs
Publication statusPublished - Oct 1 2018

All Science Journal Classification (ASJC) codes

  • Hematology
  • Oncology

Cite this

Kawakami, T., Yamazaki, K., Oki, E., Shimokawa, M., Takahashi, N., Yokota, M., Tokunaga, S., Esaki, T., Gamoh, M., Maeda, A., Tsuji, Y., Sakai, A., Hatanaka, K., Shimada, Y., Shiozawa, M., Komatsu, Y., Okuda, H., Ohue, M., & Maehara, Y. (2018). Treatment pattern and outcomes of trifluridine/tipiracil therapy for metastatic colorectal cancer in the real-world data from the JFMC50 study. Annals of oncology : official journal of the European Society for Medical Oncology, 29, viii155. https://doi.org/10.1093/annonc/mdy281.013